| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.002 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |